299
Professor Mark Thompson, the lead scientist behind the project, expressed optimism about the potential impact: “The smart insulin patch represents a paradigm shift in diabetes management. It offers a personalized and automated approach to insulin delivery, easing the burden on patients and improving their adherence to treatment.”
The research team is preparing for the next phase of clinical trials to assess the smart insulin patch’s safety, efficacy, and usability in real-world scenarios. If successful, this technology could redefine how diabetes is managed globally.
